Ebastine Teva 10 mg orodisp. tabl.

País: Bélgica

Idioma: inglés

Fuente: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Ingredientes activos:

Ebastine 10 mg

Disponible desde:

Teva Pharma Belgium SA-NV

Código ATC:

R06AX22

Designación común internacional (DCI):

Ebastine

Dosis:

10 mg

formulario farmacéutico:

Orodispersible tablet

Composición:

Ebastine 10 mg

Vía de administración:

Oral use

Área terapéutica:

Ebastine

Resumen del producto:

CTI code: 390625-01 - Pack size: 10 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 390625-08 - Pack size: 100 - Commercialisation status: YES - FMD code: 05407003821994 - CNK code: 2929263 - Delivery mode: Medical prescription; CTI code: 390625-07 - Pack size: 98 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 390625-06 - Pack size: 90 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 390625-05 - Pack size: 50 - Commercialisation status: YES - FMD code: 05407003821987 - CNK code: 2929255 - Delivery mode: Medical prescription; CTI code: 390625-04 - Pack size: 40 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 390625-03 - Pack size: 30 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 390625-02 - Pack size: 20 - Commercialisation status: NO - Delivery mode: Medical prescription

Estado de Autorización:

Commercialised: Yes

Fecha de autorización:

2011-04-15